» Articles » PMID: 15013623

Immuno-characterization of the Switch of Peptide Elongation Factors EEF1A-1/EF-1alpha and EEF1A-2/S1 in the Central Nervous System During Mouse Development

Overview
Specialty Neurology
Date 2004 Mar 12
PMID 15013623
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

During early postnatal development, a switch occurs between eEF1A-1/EF-1alpha and eEF1A-2/S1, homologous peptide elongation factors, in brain, heart, and skeletal muscle; eEF1A-2/S1 becomes the major form expressed in maturity. By immunofluorescent labeling, we detected both homologues in the developing brains of wild-type and wasted mutant mice, carrying a deletion in the eEF1A-2/S1 gene; we found that brain expression of eEF1A-2/S1 protein is restricted to mature, terminally differentiated neurons, and coincides with the disappearance of eEF1A-1/EF-1alpha 20 days after birth. Furthermore, no elongation factor 1A is present in wasted mutant mice neurons following the developmental switch, indicating that the genetic regulation silencing eEF1A-1/EF-1alpha is still functional.

Citing Articles

Local mitochondrial replication in the periphery of neurons requires the eEF1A1 protein and thetranslation of nuclear-encoded proteins.

Cardanho-Ramos C, Simoes R, Wang Y, Faria-Pereira A, Bomba-Warczak E, Craessaerts K iScience. 2024; 27(4):109136.

PMID: 38510136 PMC: 10951640. DOI: 10.1016/j.isci.2024.109136.


Face-valid phenotypes in a mouse model of the most common mutation in EEF1A2-related neurodevelopmental disorder.

Marshall G, Fasol M, Davies F, Le Seelleur M, Fernandez Alvarez A, Bennett-Ness C Dis Model Mech. 2024; 17(6).

PMID: 38179821 PMC: 10855229. DOI: 10.1242/dmm.050501.


Oncogenic activation of EEF1A2 expression: a journey from a putative to an established oncogene.

Patel S, Hassan M, Dixit M Cell Mol Biol Lett. 2024; 29(1):6.

PMID: 38172654 PMC: 10765684. DOI: 10.1186/s11658-023-00519-9.


Insulin-Like Growth Factor-1 Supplementation Promotes Brain Maturation in Preterm Pigs.

Christiansen L, Holmqvist B, Pan X, Holgersen K, Lindholm S, Henriksen N eNeuro. 2023; 10(4).

PMID: 36973010 PMC: 10112548. DOI: 10.1523/ENEURO.0430-22.2023.


Analysis of the Expression and Subcellular Distribution of and mRNAs during Neurodevelopment.

Wefers Z, Alecki C, Huang R, Jacob-Tomas S, Vera M Cells. 2022; 11(12).

PMID: 35741005 PMC: 9220863. DOI: 10.3390/cells11121877.


References
1.
Kristensen P, Lund A, Clark B, Cavallius J, Merrick W . Purification and characterisation of a tissue specific elongation factor 1 alpha (EF-1 alpha 2) from rabbit muscle. Biochem Biophys Res Commun. 1998; 245(3):810-4. DOI: 10.1006/bbrc.1998.8510. View

2.
Negrutskii B, Elskaya A . Eukaryotic translation elongation factor 1 alpha: structure, expression, functions, and possible role in aminoacyl-tRNA channeling. Prog Nucleic Acid Res Mol Biol. 1998; 60:47-78. DOI: 10.1016/s0079-6603(08)60889-2. View

3.
Gangwani L, Mikrut M, Davis R . Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells. J Cell Biol. 1998; 143(6):1471-84. PMC: 2132977. DOI: 10.1083/jcb.143.6.1471. View

4.
Duttaroy A, Bourbeau D, Wang X, Wang E . Apoptosis rate can be accelerated or decelerated by overexpression or reduction of the level of elongation factor-1 alpha. Exp Cell Res. 1998; 238(1):168-76. DOI: 10.1006/excr.1997.3819. View

5.
Lee S, Leblanc A, Duttaroy A, Wang E . Terminal differentiation-dependent alteration in the expression of translation elongation factor-1 alpha and its sister gene, S1, in neurons. Exp Cell Res. 1995; 219(2):589-97. DOI: 10.1006/excr.1995.1268. View